Transaction #30652 · Form 4 · 0001193125-26-414667
CORCEPT THERAPEUTICS INC · Stock award · Stock Option (right to buy)
CORCEPT THERAPEUTICS INC · Transacted October 1, 2026 · Filed October 5, 2026
What does this filing report?
An SEC Form 4 filing for CORCEPT THERAPEUTICS INC records a stock award involving Stock Option (right to buy) on October 1, 2026. The reported quantity was 100,000. The filing date is October 5, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- CORCEPT THERAPEUTICS INC
- Company CIK
- 0001088856
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 100,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 100,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 5, 2026, 7:44 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Gunn Justin Frederick ↗
See Remarks
CIK 0002155454
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 100,000
- Conversion / exercise price
- 114.025
- Exercise date
- Not reported
- Expiration date
- October 1, 2036
Filing footnotes & remarks
- F1
- Exercisable ratably in equal installments on each monthly anniversary of October 1, 2026 over a four-year period subject to the Reporting Person's continued service through each vesting date.
Remarks
President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.